JPH05306238A - Specific antibody and composition for controlling infectious disease of silkworm - Google Patents

Specific antibody and composition for controlling infectious disease of silkworm

Info

Publication number
JPH05306238A
JPH05306238A JP4131927A JP13192792A JPH05306238A JP H05306238 A JPH05306238 A JP H05306238A JP 4131927 A JP4131927 A JP 4131927A JP 13192792 A JP13192792 A JP 13192792A JP H05306238 A JPH05306238 A JP H05306238A
Authority
JP
Japan
Prior art keywords
silkworm
antibody
infectious disease
specific antibody
pathogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4131927A
Other languages
Japanese (ja)
Inventor
Ken Tsuda
憲 津田
Hajime Hatta
一 八田
Masaru Fujiki
優 藤木
Busaku Kin
武祚 金
Hajime Mori
肇 森
Michio Himeno
道夫 姫野
Keizo Hayashiya
慶三 林屋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Kagaku KK
Original Assignee
Taiyo Kagaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku KK filed Critical Taiyo Kagaku KK
Priority to JP4131927A priority Critical patent/JPH05306238A/en
Publication of JPH05306238A publication Critical patent/JPH05306238A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a specific antibody effective in controlling silkworm infectious disease and having binding activity to silkworm virus used in passive immunity and a silkworm infectious disease control composition containing this antibody as an active ingredient. CONSTITUTION:Objective specific antibody against pathogen (one or more kinds of viral pathogens selected from nuclear polyhedrosis virus, cytoplasmic polyhedrosis virus and flacherie) of silkworm infectious disease, preferably a hen egg antibody obtained from an egg of a hen hyper-immunized with the pathogen or a milk antibody obtained from milk of mammal such as cow, sheep and goat hyper-immunized with the pathogen, especially hen egg antibody. The objective silkworm infectious disease control composition contains its antibody as an active ingredient. The silkworm infectious disease is effectively controlled using a feed in which this antibody is blended.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、カイコの感染症病原体
に対し特異的に結合活性を有する抗体及び該抗体を配合
した飼料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antibody having a specific binding activity to an infectious disease pathogen of Bombyx mori and a feed containing the antibody.

【0002】[0002]

【従来の技術】カイコは、古来より絹の生産源として、
世界中で大量飼育されている。また、大規模養蚕を支え
る技術として、桑の葉を含まないか、又は粉末化した桑
葉を一定の割合で添加した人工飼料の開発が活発に進め
られてきた。近年の蚕用人工飼料の著しい発展により、
天然の桑の葉を用いて飼育した場合と比べて、カイコの
成長速度、成育の均一性、得られる繭の質などの点にお
いて遜色のない大量飼育方法がほぼ確立したと言える。
しかし、その反面、人工飼料で飼育しているカイコは各
種感染症に罹りやすい傾向があると言われる。カイコに
は色々な病気があるが、特にウイルス病は最も伝染力が
強く、被害が大きい。現在、カイコの病原性ウイルスと
して、核多角体病ウイルス、細胞質多角体病ウイルス、
軟化病ウイルスの3種が報告されている。
2. Description of the Related Art Silkworms have been a source of silk since ancient times.
It is bred in large quantities all over the world. In addition, as a technique for supporting large-scale sericulture, the development of an artificial feed containing no mulberry leaves or powdered mulberry leaves added at a fixed ratio has been actively promoted. With the remarkable development of artificial feed for silkworms in recent years,
It can be said that a mass-rearing method that is comparable to the growth rate of silkworms, the uniformity of growth, the quality of the resulting cocoons, etc. has been established, compared with the case of using natural mulberry leaves.
However, on the other hand, it is said that silkworms bred with artificial feed tend to be susceptible to various infectious diseases. There are various diseases in silkworms, but viral diseases are most contagious and the damage is great. Currently, silkworm pathogenic viruses include nuclear polyhedrosis virus, cytoplasmic polyhedrosis virus,
Three types of softening virus have been reported.

【0003】これらウイルス性感染症に対する防除対策
として、抗生物質などが検討されているが、カイコの成
長に影響を与えず、効果的に疾病を予防または治療する
薬剤は今だ開発されていない。唯一、酵母細胞から抽出
したトランスファ−リボ核酸を飼料に添加することによ
り、カイコ核多角体病を抑制する方法(特公昭62−3
6488)が報告されているのみである。
Antibiotics and the like have been studied as a control measure against these viral infectious diseases, but a drug that does not affect the growth of silkworms and effectively prevents or treats the disease has not been developed yet. The only method for suppressing nuclear polyhedrosis of the silkworm by adding transfer-ribonucleic acid extracted from yeast cells to the feed (Japanese Patent Publication No. 62-3
6488) has only been reported.

【0004】ウイルス性感染症を予防する手段として、
人または家畜などでは、一般的にワクチン接種が行われ
ている。すなわち、不活化したウイルスまたはウイルス
構成成分を人または家畜に接種することにより、個体自
身の持っている免疫能力を賦活化し、病原体に対する抵
抗力を増加させるものである。ワクチン接種を受けた個
体は、ウイルスに対する特異的抗体を自身の体内に準備
し、その後の感染に備える。この特異的抗体産生能力
は、脊椎動物のような高等動物が持つ自己防衛機能の重
要な位置を占めている。
As a means of preventing viral infections,
Vaccination is generally performed in humans or livestock. That is, by inoculating a human or livestock with an inactivated virus or virus constituents, the immune capacity of the individual is activated and the resistance to pathogens is increased. Vaccinated individuals prepare their own specific antibodies against the virus in preparation for subsequent infection. This specific antibody-producing ability occupies an important position in the self-defense function of higher animals such as vertebrates.

【0005】一方、カイコを含む昆虫類では、このよう
な特異的抗体を体内に準備する能力がないと言われる。
従って、カイコウイルス病を予防する目的でワクチン接
種することは意味がない。
On the other hand, it is said that insects including silkworms have no ability to prepare such a specific antibody in the body.
Therefore, there is no point in vaccination for the purpose of preventing silkworm virus disease.

【0006】ワクチン接種の他にウイルス性感染症を防
除する手段として、受動免疫がある。受動免疫とは、ウ
イルスに対する特異的抗体を予め経口的に投与してお
き、その後の感染を抑制する方法である。
[0006] In addition to vaccination, passive immunization is another means for controlling viral infections. Passive immunization is a method in which a specific antibody against a virus is orally administered in advance and the subsequent infection is suppressed.

【0007】受動免疫の公知例としては、虫歯菌(スト
レプトコッカスミュ−タンス菌)に対する特異的抗体を
用いた虫歯の予防(J.Dent.Res., 70, 162-166, 1991
年)、ロタウイルスに対する特異的抗体を用いたロタウ
イルス性下痢症の予防(Microbiol.Immunol., 34, 617-
629, 1990 年)等が報告されている。
As a known example of passive immunization, prevention of dental caries using a specific antibody against dental caries (Streptococcus mutans) (J. Dent. Res., 70, 162-166, 1991)
, Rotavirus diarrhea prevention using specific antibodies against rotavirus (Microbiol. Immunol., 34, 617-
629, 1990) etc. have been reported.

【0008】また、養殖分野における受動免疫の公知例
では、ブリ類結節症の予防、ヒラメ稚魚腸管白濁症の予
防など、魚類の感染症に対する特異的抗体の有効性につ
いて報告されている(特開平1−168246)。
[0008] In addition, in a known example of passive immunity in the field of aquaculture, the effectiveness of specific antibodies against fish infectious diseases such as prevention of yellowtail nodule disease and prevention of flounder fry intestinal tract opacification has been reported (Japanese Patent Laid-Open No. Hei 10 (1999) -242945). 1-168246).

【0009】しかしながら、カイコ等の昆虫類のウイル
ス性感染症に対して、受動免疫が有効かどうかについて
の報告は全くない。生体機能的にも、ライフサイクル面
からも脊椎動物とは全く異質のカイコにおいて、特異的
抗体を投与する受動免疫法の有効性を類推することは困
難である。
However, there is no report on whether passive immunity is effective against viral infections of insects such as silkworms. It is difficult to analogize the effectiveness of the passive immunization method in which specific antibodies are administered to silkworms, which are completely different from vertebrates both in terms of biological function and life cycle.

【0010】[0010]

【発明が解決しようとする課題】天然の桑の葉を使わな
い人工飼料の開発の飛躍的な発展により、大規模養蚕が
可能となった。しかし、桑葉を用いていた場合よりウイ
ルス性感染症が多発するという問題が発生し、養蚕業界
に大きな被害をもたらしている。ウイルス性感染症に対
しては、抗生物質等の開発も進められているが、今だ、
顕著な防御効果を見るまでにはいたっていない。また、
薬剤の使用がカイコの成育に影響を与えるなどの問題点
も指摘されている。
[Problems to be Solved by the Invention] The dramatic development of artificial feed that does not use natural mulberry leaves has enabled large-scale sericulture. However, there is a problem that viral infections occur more frequently than when mulberry leaves are used, which causes great damage to the sericulture industry. Antibiotics are being developed for viral infections, but
It isn't enough to see a noticeable protective effect. Also,
It has also been pointed out that the use of drugs affects the growth of silkworms.

【0011】本発明の目的は、受動免疫法、すなわち特
異的抗体をカイコに投与することにより、カイコのウイ
ルス性感染症を防除することにある。また、該受動免疫
で用いられるカイコウイルスに対し結合活性を有する特
異的抗体を提供することにある。さらには、該特異的抗
体を配合したカイコウイルス性感染症防除に有効な組成
物を提供することにある。
[0011] An object of the present invention is to prevent viral infection of silkworms by the passive immunization method, that is, by administering specific antibodies to silkworms. Another object is to provide a specific antibody having a binding activity to the silkworm virus used in the passive immunization. Further, it is to provide a composition containing the specific antibody, which is effective for controlling silkworm-borne infectious diseases.

【0012】[0012]

【課題を解決する為の手段】本発明者らは、前記課題を
解決するために、カイコ感染症の防除方法として受動免
疫に着目し、研究を進めた結果、カイコのウイルスに対
する特異的抗体の調製に成功した。また、該特異的抗体
を配合した組成物としてカイコの飼料を調製し、該特異
的抗体の経口投与によるカイコのウイルス性感染症の受
動免疫効果について、初めて実証した。即ち、本発明
は、カイコ感染症の防除に用いる特異的抗体及び該抗体
を配合してなるカイコ感染症防除組成物に関する。
[Means for Solving the Problems] In order to solve the above problems, the present inventors focused their attention on passive immunity as a method for controlling silkworm infectious diseases, and as a result of conducting research, The preparation was successful. In addition, the silkworm feed was prepared as a composition containing the specific antibody, and the oral immunization of the specific antibody demonstrated the passive immunity effect on the viral infection of the silkworm for the first time. That is, the present invention relates to a specific antibody used for controlling silkworm infectious disease and a composition for controlling silkworm infectious disease containing the antibody.

【0013】本発明のカイコ感染症とは、核多角体病ウ
イルス、細胞質多角体病ウイルス、軟化病ウイルスその
他のウイルス性病原体による感染症を言う。
The silkworm infectious disease of the present invention means an infectious disease caused by a viral pathogen such as a nuclear polyhedrosis virus, a cytoplasmic polyhedrosis virus, an emollient virus and the like.

【0014】本発明の特異的抗体とは、カイコの感染症
病原体に対して特異的に結合する抗体を言い、抗体の種
類としては、カイコ感染症病原体で過免疫された産卵鶏
の卵より得られる鶏卵抗体、あるいはカイコ感染症病原
体で過免疫された哺乳類の乳汁より得られる乳汁抗体を
言い、その抗体純度については限定しない。即ち、抗体
の純品であってもよいし、鶏卵抗体の場合はそれを含む
全卵粉末、卵黄粉末、あるいは卵黄の水溶性蛋白質画分
粉末であってもよい。また、乳汁抗体の場合はそれを含
む全脂粉乳、脱脂粉乳、あるいは乳清蛋白質粉末であっ
てもよい。
The specific antibody of the present invention means an antibody that specifically binds to a pathogen of a silkworm infectious disease, and the type of antibody is obtained from eggs of laying hens hyperimmunized with a pathogen of a silkworm infectious disease. It is a chicken egg antibody or a milk antibody obtained from milk of a mammal hyperimmunized with a silkworm infectious disease pathogen, and the antibody purity is not limited. That is, it may be a pure antibody, or in the case of a chicken egg antibody, whole egg powder, egg yolk powder, or water-soluble protein fraction powder of egg yolk containing it. In the case of a milk antibody, it may be whole milk powder, skim milk powder containing it, or whey protein powder.

【0015】カイコ感染症病原体で過免疫される動物と
しては、該病原体に対する特異的抗体を産生できる動物
であればよいが、本発明の目的であるカイコ感染症の防
除に用いられる抗体及びその抗体組成物の提供という実
用的観点から考えると、大量の特異的抗体を産生できる
産卵鶏、あるいは牛、ヤギ、羊等の哺乳類に限定され
る。これらの中でも、過免疫の作業性、抗体産生能力、
動物飼育コスト等の観点から、産卵鶏に病原体を免疫
し、その鶏卵より抗体を得る方法が最も望ましい。
The animal hyperimmunized with the pathogen of the silkworm infectious disease may be any animal capable of producing a specific antibody against the pathogen, but the antibody and its antibody used for controlling the silkworm infectious disease which is the object of the present invention. From the practical point of view of providing the composition, it is limited to laying hens or mammals such as cows, goats, and sheep that can produce large amounts of specific antibodies. Among these, hyperimmunity workability, antibody production ability,
From the viewpoint of animal breeding costs and the like, the most preferable method is to immunize a laying hen with a pathogen and obtain an antibody from the hen's egg.

【0016】産卵鶏を過免疫する方法としては、カイコ
の感染症病原体を抗原として産卵鶏に繰り返し投与する
ことにより、鶏卵中に特異的抗体を増加させるとよい。
また、哺乳類を過免疫する方法としては、牛、ヤギ、羊
等の動物に該抗原を繰り返し投与することにより、乳汁
中に特異的抗体を増加させるとよい。
As a method of hyperimmunizing laying hens, it is advisable to repeatedly administer the infectious disease pathogen of silkworm to the laying hens as an antigen to increase the specific antibody in the eggs.
As a method for hyperimmunizing mammals, it is advisable to repeatedly administer the antigen to animals such as cows, goats, and sheep to increase the specific antibody in milk.

【0017】この場合用いられる抗原の調製について
は、公知の方法で行えばよい。例えば、カイコ感染症の
病原ウイルスを大量培養した後、ホルマリン等の公知の
不活化剤で処理することにより、抗原の大量調製が可能
である。または、感染症で斃死したカイコを集め、その
罹患部をホモジネ−ション等の方法で均質化し、抗原と
することも可能である。または、罹患部のホモジネ−ト
中に含まれる病原ウイルスの純度を上昇させる目的で、
遠心分離、カラムクロマトグラフィ−、濾過などの公知
の方法を組み合わせることにより、病原ウイルスを精製
し、抗原として用いることも可能である。
The antigen used in this case may be prepared by a known method. For example, a large amount of antigen can be prepared by culturing a large amount of a pathogenic virus for silkworm infectious disease and then treating it with a known inactivating agent such as formalin. Alternatively, it is also possible to collect silkworms killed by an infectious disease, homogenize the affected part by a method such as homogenization, and use it as an antigen. Alternatively, for the purpose of increasing the purity of the pathogenic virus contained in the homogenate of the affected part,
It is also possible to purify the pathogenic virus and use it as an antigen by combining known methods such as centrifugation, column chromatography and filtration.

【0018】抗原を産卵鶏あるいは哺乳類に投与する方
法としては、筋肉注射、皮下注射、静脈注射、腹腔内注
射、あるいは飲水による経口投与等、一般的な投与法が
用いられるが、操作性及び特異的抗体の産生効率などの
観点より筋肉注射が望ましい。投与に用いられる抗原
は、カイコ感染症病原体の溶液又は浮遊けん濁液、ある
いは該液と水酸化アルミニウムゲルやフロイントアジュ
バントを混合したものが一般的に用いられる。
As a method for administering the antigen to the laying hen or mammal, a general administration method such as intramuscular injection, subcutaneous injection, intravenous injection, intraperitoneal injection, or oral administration by drinking water is used, but operability and specificity are used. Intramuscular injection is preferable from the viewpoint of production efficiency of specific antibody. The antigen used for administration is generally a solution or suspension of silkworm infectious disease pathogen, or a mixture of the solution and an aluminum hydroxide gel or Freund's adjuvant.

【0019】抗原の投与は、鶏卵中あるいは乳汁中に現
れる特異的抗体量を酵素免疫測定法などの方法で調べな
がら、該抗体量が最大値になるまで繰り返し実施され
る。なお、該抗体量は、適当な間隔で産卵鶏あるいは哺
乳類に抗原を繰り返し投与することにより、産卵期間ま
たは乳汁分泌期間を通してある一定レベル以上の特異的
抗体量を維持することができる。
The administration of the antigen is repeated until the amount of the antibody reaches the maximum value while examining the amount of the specific antibody appearing in the egg or the milk by a method such as enzyme immunoassay. The amount of the antibody can be maintained at a certain level or more throughout the spawning period or the lactation period by repeatedly administering the antigen to the hens or mammals at appropriate intervals.

【0020】投与される抗原の量は、被投与動物の種
類、抗原の種類等により異なるため、適時、予備試験等
により選択する必要があるが、産卵鶏への投与の場合、
一般的には、ウイルス量として10μg〜1mg/羽/回
の抗原量が選択される。
Since the amount of the antigen to be administered depends on the type of animal to be administered, the type of antigen, etc., it is necessary to select it in a timely and preliminary test, but in the case of administration to laying hens,
Generally, an antigen amount of 10 μg to 1 mg / bird / dose is selected as the viral amount.

【0021】カイコ感染症病原体を抗原として産卵鶏あ
るいは哺乳類に投与した後、該抗原に対する特異的抗体
を含有する鶏卵あるいは乳汁を集め、これより本発明の
カイコ感染症の防除に用いられるカイコ感染症病原体に
対する特異的抗体を調製することができる。鶏卵を用い
る場合、割卵後、全卵液または卵黄液を分離し、ホモジ
ナイザ−等で均質化した後、殺菌し熱風乾燥あるいは凍
結乾燥により用いた抗原に対する特異的抗体含有全卵粉
末あるいは卵黄粉末を得ることができる。また、該卵黄
液または卵黄粉末より公知の鶏卵抗体精製法(特開昭6
4−38098、Agric.Biol.Chem. 54(10)、2531-253
5 、1990年等)により、用いた抗原に対する特異的抗体
純度を高めた卵黄水溶性タンパク質粉末あるいは特異的
抗体の純品粉末等が調製できる。乳汁を用いる場合、該
乳汁あるいは該乳汁中の脂質成分をクリ−ムセパレ−タ
−等で分離した脱脂乳を殺菌後、熱風乾燥あるいは凍結
乾燥し用いた抗原に対する特異的抗体を含有する全脂粉
乳あるいは脱脂粉乳が得られる。また該乳汁あるいは該
脱脂乳より、公知の方法で用いた抗原に対する特異的抗
体純度を高めたホエ−タンパク質粉末あるいは特異的抗
体の純品等が調製できる。
After the silkworm infectious disease pathogen is administered as an antigen to laying hens or mammals, hen's eggs or milk containing a specific antibody against the antigen is collected and used to control the silkworm infectious disease of the present invention. Specific antibodies to the pathogen can be prepared. When using chicken eggs, whole egg liquid or yolk liquid is separated after egg splitting, homogenized with a homogenizer, etc., and sterilized and dried by hot air or freeze drying. Can be obtained. Further, a known method for purifying an egg egg antibody from the egg yolk liquid or egg yolk powder (Japanese Patent Laid-Open No. 6-58242)
4-38098, Agric. Biol. Chem. 54 (10), 2531-253.
5, 1990, etc.), an egg yolk water-soluble protein powder or a pure antibody powder having a high specific antibody purity against the used antigen can be prepared. When milk is used, the whole milk powder containing a specific antibody against the antigen used after sterilizing the skim milk obtained by separating the milk or the lipid component in the milk with a cream separator, etc., and then using hot air drying or freeze drying Alternatively, skim milk powder is obtained. Further, from the milk or the skim milk, a whey protein powder having a high specific antibody purity against an antigen used by a known method or a pure specific antibody can be prepared.

【0022】本発明のカイコ感染症防除組成物とは、カ
イコ感染症の病原体に対する特異的抗体として過免疫鶏
の卵より得られる全卵粉末、卵黄粉末、卵黄水溶性タン
パク質粉末、鶏卵抗体純品粉末、あるいは過免疫哺乳類
の乳汁より得られる全脂粉乳、脱脂粉乳、ホエ−タンパ
ク質粉末、乳汁抗体純品粉末等の粉末をカイコ感染症の
防除有効成分として配合した組成物を言う。組成物の他
の補助成分として、ビタミン、ミネラル類、カイコの摂
食誘引物質等、抗生物質などを同時に配合することがで
きる。
The silkworm infection control composition of the present invention means whole egg powder, egg yolk powder, egg yolk water-soluble protein powder, chicken egg antibody pure product obtained as a specific antibody against the pathogen of silkworm infection, from eggs of hyperimmune chickens. It refers to a composition in which powder, or powdered whole milk powder, skim milk powder, whey protein powder, milk antibody pure product powder, etc., obtained from milk of a hyperimmune mammal is mixed as an active ingredient for controlling silkworm infections. As other auxiliary ingredients of the composition, vitamins, minerals, silkworm feeding attractants, antibiotics and the like can be simultaneously added.

【0023】本発明の組成物の給餌における形態として
は、稚蚕期はスライス状、リボン状、また壮蚕期はリボ
ン状、ブロック状のものが望ましいが、カイコが摂食で
きればどのような形態でもよい。また、カイコ感染症病
原体に対する特異的抗体を含有する粉末を他の補助成分
とともに水に懸濁することにより液剤とし、カイコ用飼
料に塗布して用いてもよい。
The composition of the present invention is preferably fed in the form of slices or ribbons during the juvenile period, or ribbons or blocks during the period of larval silkworms. Whatever form the silkworm can eat. But it's okay. Alternatively, a powder containing a specific antibody against a pathogen of a silkworm infectious disease may be suspended in water together with other auxiliary components to prepare a liquid agent, which may be applied to a silkworm feed for use.

【0024】[0024]

【実施例】以下、実施例、試験例により本発明をさらに
詳しく説明するが、本発明はこれらの実施例によりなん
ら制限されるものではない。 実施例1.カイコ核多角体病ウイルスに対する鶏卵抗体
の調製 (抗原)カイコの多角体(ウイルスの封入体)500 mg
を、0.5 %炭酸ナトリウム水溶液50mlに懸濁し、0
℃、30分間攪拌した。pHを8.5 に調製後、4000rpm ,
15分間遠心分離し、その上清をウイルス粗精製液として
さらに超遠心分離法により、ウイルスの精製を行った。
すなわち、48,000g,90分間超遠心分離した後、得られ
た沈殿(ウイルス)を10mMTris-HCl(pH 8.5)に懸
濁した。さらにもう一度4,000 rpm ,15分間遠心分離
し、その上清を48,000g,90分間超遠心分離した。得ら
れた沈殿を10mMTris-HCl(pH 8.5)懸濁したものを
最終的に精製ウイルス抗原液(1mg/ml)とした。 (免疫)産卵鶏3羽に対し、精製ウイルス抗原液(1m
g/ml)をフロイントコンプリ−トアジュバントと同
量混合乳化したものを、1羽当たり2ml筋肉内に免疫
注射した。免疫注射は毎週1回で合計4回行った。 (鶏卵抗体の調製)抗原に対する特異的抗体力価の上昇
した鶏卵(免疫1ケ月後より5ケ月間)を割卵し、卵黄
液4.4 kgを得た。該卵黄液をスプレ−ドライ法(入風
温度150 ℃、排風温度80℃)で粉末化し、カイコ核多角
体病ウイルスに対する鶏卵抗体(卵黄粉末)2.1 kgを
得た。
EXAMPLES The present invention will be described in more detail with reference to Examples and Test Examples, but the present invention is not limited to these Examples. Example 1. Preparation of chicken egg antibody against Bombyx mori polyhedrosis virus (antigen) Bombyx mori polyhedron (virus inclusion body) 500 mg
Was suspended in 50 ml of 0.5% aqueous sodium carbonate solution,
The mixture was stirred at 0 ° C for 30 minutes. After adjusting the pH to 8.5, 4000 rpm,
The cells were centrifuged for 15 minutes, and the supernatant was used as a crude virus purification solution to further purify the virus by the ultracentrifugation method.
That is, after ultracentrifugation at 48,000 g for 90 minutes, the obtained precipitate (virus) was suspended in 10 mM Tris-HCl (pH 8.5). The solution was centrifuged again at 4,000 rpm for 15 minutes, and the supernatant was ultracentrifuged at 48,000 g for 90 minutes. A suspension of the obtained precipitate in 10 mM Tris-HCl (pH 8.5) was finally used as a purified virus antigen solution (1 mg / ml). (Immunity) Purified virus antigen solution (1m
(g / ml) was mixed and emulsified with Freund's complete adjuvant in the same amount, and 2 ml was intramuscularly injected per animal. Immune injection was performed once a week for a total of 4 times. (Preparation of Chicken Egg Antibody) Eggs (for 5 months from 1 month after immunization) having an increased titer of specific antibody against the antigen were cleaved to obtain 4.4 kg of yolk liquid. The egg yolk liquid was pulverized by a spray-dry method (air temperature of 150 ° C., air temperature of 80 ° C.) to obtain 2.1 kg of chicken egg antibody (yolk powder) against silkworm nuclear polyhedrosis virus.

【0025】実施例2.カイコウイルス感染症防除飼料
の調製 <蚕用基本人工飼料> 桑葉粉末 31% 脱脂大豆粉末 20% セルロ−ス粉末 20% 寒天 10% 馬鈴薯澱粉 10% ビタミンC 2% クエン酸 2% ミネラル混合 2% プロピオン酸 1% ビタミンB群 1% 大豆油 1% 蚕用基本人工飼料100 gに対し水240 g加え、よく混合
した後、オ−トクレ−ブで高圧滅菌処理した。該人工飼
料170 gに対し、カイコ核多角体病ウイルスに対する鶏
卵抗体(卵黄粉末)の懸濁液(20mg/ml)を17ml
滴下し、よくしみこませてカイコウイルス感染症防除飼
料187 gを得た。
Example 2. Preparation of feed for controlling silkworm virus infection <Basic artificial feed for silkworm> Mulberry leaf powder 31% Skim soybean powder 20% Cellulose powder 20% Agar 10% Potato starch 10% Vitamin C 2% Citric acid 2% Mineral mixture 2% Propionic acid 1% Vitamin B group 1% Soybean oil 1% To 100 g of a basic artificial diet for silkworms, 240 g of water was added and mixed well, followed by autoclaving with an autoclave. 17 ml of a suspension (20 mg / ml) of chicken egg antibody (yolk powder) against silkworm nuclear polyhedrosis virus was added to 170 g of the artificial feed.
The mixture was added dropwise and thoroughly soaked to obtain 187 g of a feed for controlling silkworm virus infection.

【0026】試験例1.鶏卵抗体の抗体力価測定 鶏卵抗体の抗体力価は酵素免疫測定法(ELISA)に
より測定した。基本的な手順を以下に示す。 (1)ELISAプレ−ト:96穴ポリスチレンプレ−
ト(ヌンク社製)を用いた。 (2)抗原のコ−ティング:免疫に用いた精製ウイルス
抗原液を0.05M炭酸緩衝液(pH9.6 )で10μg/m
lに希釈し、その100 μlをELISAプレ−トの各ウ
エルへ添加し、5℃、一夜放置した。 (3)洗浄:0.5 %Tween20含有20mMリン酸緩
衝液(pH7.4 、以下PBS−Tweenと略す。)を
ウエル当たり200 μl添加して洗浄した。洗浄は4回行
った。 (4)ブロッキング:10mg/mlオボアルブミン含有
PBS−Tweenをウエル当たり100 μl添加し、37
℃、1時間放置した。 (5)洗浄:(3)と同様に行った。 (6)サンプル添加:PBS−Tweenで希釈したサ
ンプル液を100 μl/ウエルで添加し、37℃、1時間放
置した。 (7)洗浄:(3)と同様に行った。 (8)2次抗体添加:抗ニワトリIgGウサギIgG−
アルカリホスファタ−ゼコンジュゲ−ト(ザイメット社
製)をPBS−Tweenで2,000 倍希釈し100 μl/
ウエルで添加し、37℃、1時間放置した. (9)洗浄:3)と同様に行った。 (10)酵素反応:基質として、シグマ社製のP−ニトロ
フェニルホスフェ−ト・210 を用いた。基質1mg/m
lを溶解した0.1 Mエタノ−ルアミン緩衝液(pH9.8
)をウエル当たり100 μl添加し、37℃、20分間酵素
反応を行った後、2MNaOH溶液を50μl/ウエル添
加し、反応を停止した。 (11)吸光度測定:各ウエルの405 nmにおける吸光度
を測定し、ブランク(サンプルの代わりにPBS−Tw
eenを添加したウエル)の吸光度を差し引いた値をE
LISA値とした。
Test Example 1. Antibody titer measurement of chicken egg antibody The antibody titer of chicken egg antibody was measured by enzyme-linked immunosorbent assay (ELISA). The basic procedure is shown below. (1) ELISA plate: 96-well polystyrene plate
(Manufactured by Nunc) was used. (2) Antigen coating: The purified virus antigen solution used for immunization was 0.05 μM carbonate buffer (pH 9.6) at 10 μg / m 2.
It was diluted to 1 and 100 μl was added to each well of the ELISA plate and left overnight at 5 ° C. (3) Washing: 200 μl / well of 20 mM phosphate buffer containing 0.5% Tween 20 (pH 7.4, abbreviated as PBS-Tween hereinafter) was added and washed. Washing was performed 4 times. (4) Blocking: 100 μl of PBS-Tween containing 10 mg / ml ovalbumin was added per well, and 37
It was left at ℃ for 1 hour. (5) Washing: The same as (3). (6) Addition of sample: A sample solution diluted with PBS-Tween was added at 100 μl / well and left at 37 ° C. for 1 hour. (7) Washing: The same as (3). (8) Addition of secondary antibody: anti-chicken IgG rabbit IgG-
Alkaline phosphatase conjugate (manufactured by Zymet) was diluted 2,000 times with PBS-Tween to give 100 μl /
The wells were added and left at 37 ° C for 1 hour. (9) Washing: The same as 3). (10) Enzymatic reaction: P-nitrophenyl phosphate.210 manufactured by Sigma was used as a substrate. Substrate 1 mg / m
0.1 M ethanolamine buffer solution (pH 9.8)
) Was added to each well and the enzyme reaction was carried out at 37 ° C. for 20 minutes, and then 50 μl / well of 2M NaOH solution was added to stop the reaction. (11) Absorbance measurement: The absorbance at 405 nm of each well was measured, and a blank (instead of the sample, PBS-Tw was used).
The value obtained by subtracting the absorbance of the well to which een was added is E
It was set as the LISA value.

【0027】実施例1の免疫の結果得られた鶏卵卵黄に
ついて、カイコ核多角体病ウイルスに対する特異的抗体
力価をELISAにより測定した。すなわち免疫後、1
週毎の鶏卵卵黄を分取して、PBS−Tweenで500
倍希釈したものをELISA用のサンプルとして供し
た。図1にカイコ核多角体病ウイルスに対する特異的抗
体力価の推移を示す。毎週計4回の免疫により、抗体力
価の上昇が見られることがわかった。
The egg yolk obtained as a result of immunization in Example 1 was assayed for the specific antibody titer against silkworm nuclear polyhedrosis virus by ELISA. That is, after immunization, 1
Egg yolk is collected every week and 500 with PBS-Tween
The double-diluted product was used as a sample for ELISA. Figure 1 shows the changes in the specific antibody titer against the silkworm nuclear polyhedrosis virus. It was found that an increase in antibody titer was observed after a total of four immunizations each week.

【0028】試験例2.カイコ核多角体病に対する鶏卵
抗体の効果 実施例2で調製したカイコウイルス感染症防除飼料187
gの上に、3齢3日目のカイコ20頭を置き、2日間添食
した。この際、対照として、抗原で免疫していない鶏卵
卵黄粉末を蚕用基本人工飼料に同濃度添加した飼料を与
える群も用意した。又、蚕用基本人工飼料のみを与える
群も用意した。一方、精製した多角体(ウイルス封入
体)をペニシリンおよびストレプトマイシンで消毒し、
滅菌水に懸濁したものをさらに滅菌水で10段階希釈し
た。このウイルス希釈液1mlを蚕用基本人工飼料2g
に滴下し、十分にしみこませたものをカイコが4齢起蚕
になった時に与え、24時間添食させ、その後の核多角
体病の発症を観察した。特異的鶏卵抗体(卵黄粉末)添
加飼料投与群、対照卵黄粉末添加飼料投与群および無添
加飼料投与群における核多角体病の発症率を表1に示
す。
Test Example 2. Effect of hen egg antibody on silkworm nuclear polyhedrosis Disease feed for controlling silkworm virus infection prepared in Example 2 187
Twenty silkworms on the third day of the third day were placed on the g and fed for 2 days. At this time, as a control, a group was also provided in which a chicken egg yolk powder not immunized with the antigen was added to the basic artificial diet for the silkworm at the same concentration. In addition, a group to which only the artificial artificial diet for silkworm was given was also prepared. On the other hand, disinfect the purified polyhedra (virus inclusion bodies) with penicillin and streptomycin,
The suspension in sterile water was further diluted with sterile water in 10 steps. 1 ml of this virus diluted solution 2 g of basic artificial diet for silkworm
The silkworms, which had been soaked in and were sufficiently soaked, were given to the silkworms when they turned into silkworms at the 4th instar, and they were fed for 24 hours, after which the onset of nuclear polyhedrosis was observed. Table 1 shows the incidence of nuclear polyhedrosis in the group administered with the specific egg yolk antibody (yolk powder) -added feed, the group administered with the control egg yolk powder-added feed and the group administered with no additive egg yolk powder.

【0029】[0029]

【表1】 [Table 1]

【0030】ウイルス接種量1×108 個/mlにおい
て、対照卵黄粉末添加群および無添加群が100 %の発症
率を示したのに対し、特異的鶏卵抗体添加群では40%に
抑えられた。また、同接種量1×107 個/mlでは、対
照卵黄粉末添加群および無添加群が40%の発症率を示し
たのに対し、特異的鶏卵抗体添加群では0%に抑制され
た。
When the virus inoculum was 1 × 10 8 cells / ml, the control egg yolk powder-added group and the non-added group showed 100% incidence, whereas the specific egg yolk antibody-added group had an incidence of 40%. .. At the same inoculation dose of 1 × 10 7 cells / ml, the incidence was 40% in the control egg yolk powder addition group and the non-addition group, while it was suppressed to 0% in the specific egg egg antibody addition group.

【0031】[0031]

【発明の効果】カイコの飼育形態の大規模化が進むにつ
れて、ひとたび感染症が発生すると甚大な被害を受ける
ようになった。カイコの感染症の中でもウイルスによる
ものは特に被害も大きく、これを完全に予防する手段は
現在全くない。抗生物質の開発も進められているが、顕
著な防御効果を見るまでには至っていない。またカイコ
自身の成長に影響を与えるなどの問題点も残っている。
このような現状において本発明により初めて、カイコ感
染症の病原体に対する特異的抗体を用いた受動免疫によ
り、カイコ感染症の防除効果が実証された。
EFFECTS OF THE INVENTION As the breeding form of silkworms has become larger and larger, once an infectious disease has occurred, it has been seriously damaged. Among silkworm infectious diseases, viruses are particularly damaging, and there is currently no means to completely prevent them. Antibiotics are being developed, but they have not reached a remarkable protective effect. In addition, there are still problems such as affecting the growth of the silkworm itself.
Under such circumstances, the present invention has demonstrated for the first time the effect of controlling silkworm infectious disease by passive immunization using a specific antibody against the pathogen of silkworm infectious disease.

【図面の簡単な説明】[Brief description of drawings]

【図1】カイコ核多角体病ウイルスに対する特異的抗体
力価の推移を示す。
FIG. 1 shows the change in specific antibody titer against silkworm nuclear polyhedrosis virus.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 金 武祚 三重県四日市市赤堀新町9番5号 太陽化 学株式会社内 (72)発明者 森 肇 京都府京都市北区小山下内河原町27−1 (72)発明者 姫野 道夫 大阪府堺市大野芝町23大野芝宅舎3−58 (72)発明者 林屋 慶三 京都府京都市左京区北白川東伊織町31−1 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Takehisa Kin, 9-5 Akahori Shinmachi, Yokkaichi-shi, Mie, Taiyo Kagaku Co., Ltd. (72) Hajime Mori 27- 1 (72) Inventor Michio Himeno 23, Onoshiba, Onoshiba-cho, Sakai-shi, Osaka 3-58 (72) Inventor Keizo Hayashiya 31-1 Kita-Shirakawa-Higashiiori-cho, Sakyo-ku, Kyoto-shi, Kyoto

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 カイコ感染症の防除に用いられるカイコ
感染症病原体に対する特異的抗体及びその抗体を配合し
てなるカイコ感染症防除組成物及び/又はカイコ飼料。
1. A silkworm infection control composition and / or silkworm feed comprising a specific antibody against a silkworm infection pathogen used for controlling silkworm infection and the antibody.
【請求項2】 特異的抗体が、カイコ感染症病原体で過
免疫された産卵鶏の卵より得られる鶏卵抗体である請求
項1記載の特異的抗体。
2. The specific antibody according to claim 1, wherein the specific antibody is a chicken egg antibody obtained from eggs of laying hens hyperimmunized with a silkworm infectious disease pathogen.
【請求項3】 特異的抗体が、カイコ感染症病原体で過
免疫された哺乳類の乳汁より得られる乳汁抗体である請
求項1記載の特異的抗体。
3. The specific antibody according to claim 1, wherein the specific antibody is a milk antibody obtained from milk of a mammal hyperimmunized with a pathogen of a silkworm infectious disease.
【請求項4】 カイコ感染症の病原体がウイルス性の病
原体である請求項1、2および3記載の特異的抗体。
4. The specific antibody according to claim 1, 2 or 3, wherein the pathogen of Bombyx mori infection is a viral pathogen.
【請求項5】 ウイルス性の病原体が、核多角体病ウイ
ルス・細胞質多角体病ウイルス・軟化病ウイルスから選
ばれる1種又は2種以上である請求項4記載の特異的抗
体。
5. The specific antibody according to claim 4, wherein the viral pathogen is one kind or two or more kinds selected from nuclear polyhedrosis virus, cytoplasmic polyhedrosis virus, and softening disease virus.
JP4131927A 1992-04-24 1992-04-24 Specific antibody and composition for controlling infectious disease of silkworm Pending JPH05306238A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4131927A JPH05306238A (en) 1992-04-24 1992-04-24 Specific antibody and composition for controlling infectious disease of silkworm

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4131927A JPH05306238A (en) 1992-04-24 1992-04-24 Specific antibody and composition for controlling infectious disease of silkworm

Publications (1)

Publication Number Publication Date
JPH05306238A true JPH05306238A (en) 1993-11-19

Family

ID=15069463

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4131927A Pending JPH05306238A (en) 1992-04-24 1992-04-24 Specific antibody and composition for controlling infectious disease of silkworm

Country Status (1)

Country Link
JP (1) JPH05306238A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007327964A (en) * 2000-05-11 2007-12-20 Genome Soyaku Kenkyusho:Kk Method for screening compound having antimicrobial activity to pathogenic microbe infecting living thing having acquired immunologic mechanism by utilizing living thing having only natural immunologic mechanism, and method for evaluating antimicrobial activity by utilizing living thing having only natural immunologic mechanism
JP2010133975A (en) * 2000-05-11 2010-06-17 Genome Soyaku Kenkyusho:Kk Method of screening compound having antimicrobial activity on pathogenic microorganism infecting organism having acquired immune mechanism by using larva of insect having only natural immune mechanism, and method of evaluating antimicrobial activity by using larva of insect having only natural immune mechanism

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007327964A (en) * 2000-05-11 2007-12-20 Genome Soyaku Kenkyusho:Kk Method for screening compound having antimicrobial activity to pathogenic microbe infecting living thing having acquired immunologic mechanism by utilizing living thing having only natural immunologic mechanism, and method for evaluating antimicrobial activity by utilizing living thing having only natural immunologic mechanism
JP2010133975A (en) * 2000-05-11 2010-06-17 Genome Soyaku Kenkyusho:Kk Method of screening compound having antimicrobial activity on pathogenic microorganism infecting organism having acquired immune mechanism by using larva of insect having only natural immune mechanism, and method of evaluating antimicrobial activity by using larva of insect having only natural immune mechanism
JP4733080B2 (en) * 2000-05-11 2011-07-27 株式会社ゲノム創薬研究所 Method for screening compound having antibacterial activity against pathogenic microorganism infecting organism having acquired immune mechanism using organism having only innate immunity mechanism, and using organism having only innate immunity mechanism for antibacterial activity How to evaluate

Similar Documents

Publication Publication Date Title
CA2260007C (en) Method for treating gastrointestinal damage
JP2698778B2 (en) Passive immunization of mammals using avian antibodies
CA1306946C (en) Specific antibody-containing substance from eggs and method of production and use thereof
KR102295411B1 (en) Clay product and uses thereof
AU729502B2 (en) Oral administration of chicken yolk antibodies to treat disease
WO1997020577A1 (en) Improved therapeutic formulation and method
JPH08509965A (en) Therapeutic agent and method
JP2002501526A (en) Method for producing immunoglobulin A in milk
KR910005409B1 (en) Process for preparing specific antibody containing substance from eggs
JP2022513337A (en) Compositions and Methods for Treating Intestinal Infectious Diseases and Acute Diarrhea in Animals
JPH0657663B2 (en) Method for producing multifunctional specific antibody
KR102047784B1 (en) Manufacturing method of Immunoglobulin Y for preventing or treating calf digestive diseases, and Immunoglobulin Y thereby and the use thereof
JP3856345B2 (en) Intestinal protozoan vaccines
Porter Structural and functional characteristics of immunoglobulins of the common domestic species
WO1999002188A1 (en) Hen egg yolk antibodies to clostridium difficile antigens and use in therapy for pseudomembranous colitis
CN102307898A (en) Method for producing comprehensive anti-surface antibody wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent
KR20060025519A (en) Immunogen adherence and method of making and using same
Xu et al. Bovine immune colostrum against 17 strains of diarrhea bacteria and in vitro and in vivo effects of its specific IgG
US20040258664A1 (en) Multifunctional complex for targeting specific phagocytosis of a target agent
KR100267746B1 (en) Oral immunological preparation containing egg-yolk antibodies, for prevention and treatment of porcine diarrhea caused by enterotoxigenic escherichia coli
US20070253947A1 (en) Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
JPH05306238A (en) Specific antibody and composition for controlling infectious disease of silkworm
KR19980081625A (en) Prevention and treatment of infections caused by intestinal hemorrhagic E. coli
JPH05255113A (en) Specific antibody and shrimp infectious disease-controlling composition compounded with the same
JPH0356426A (en) Bovine mastitis preventive and treating antibody-containing material